Efficacy and Safety of Liraglutide in Combination With Insulin Therapy Compared to Insulin Alone in Japanese Subjects With Type 2 Diabetes
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 257 participants.
Also called NCT01572740
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 257 participants
- Sponsor
- Registry
-
NCT01572740
-
- Other papers using this trial's data
- Combination therapy with liraglutide and insulin in Japanese patients with type 2 diabetes: A 36-week, randomized, double-blind, parallel-group trial
- Efficacy and safety of adding liraglutide to existing insulin regimens in Japanese patients with type 2 diabetes mellitus: A post-hoc analysis of a phase 3 randomized clinical trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT01572740. Randomized; double masking; primary purpose treatment. Start 2012-04-05 (actual); primary completion 2012-11-01 (actual). Results posted on 2014-05-23.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Liraglutide in Combination With Insulin Therapy Compared to Insulin Alone in Japanese Subjects With Type 2 Diabetes
- Condition
- Diabetes
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- liraglutide
- Intervention (Drug)
- placebo
- Intervention (Drug)
- insulin
- Lead sponsor
- Novo Nordisk A/S
Record details
- Record id
cardio:ct-nct01572740- Content hash
8d38269ca423a43cf97a1a3ca78965a432c3dbc90628fd7d28b5fd4cc647c610